US Patent Litigations are now available. Check here

Explore patent oppositions filed by Read against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 26, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3210965Process For The Preparation Of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-PhenolGRNENTHALAug 17, 2022
EP3366283Direct Compression Formulation And ProcessNOVARTISMay 23, 2022
EP2667856Medical Device Containing A Cake Composition Comprising Aripiprazole As An Active Ingredient, And A Cake Composition Comprising Aripiprazole As An Active IngredientOTSUKA PHARMACEUTICALApr 21, 2022
EP2234617Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 10, 2021
EP3021736Contact SensorNEXTLIFE WEARABLESFeb 10, 2021
EP2341905Sustained Release Formulations Using Non-Aqueous CarriersAMYLIN PHARMACEUTICALSJan 28, 2021
EP2094246Sustained-Release Composition And Method For Producing The SameTAKEDA PHARMACEUTICALDec 16, 2020
EP3280416Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 1, 2020
EP2347762Exendin For Treating Diabetes And Reducing Body WeightAMYLIN PHARMACEUTICALSJan 21, 2020
EP2598119Preservative Free Brimonidine And Timolol SolutionsALLERGANJun 4, 2019

Explore Read's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 26, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2751612Mar 24, 2021Adjustable Refractive Optical Device1